Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma. Txagorapid Study. Intervention Pilot Study. (TxagoRapid)
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The objective of this pilot study is therefore to assess the safety of Truxima ultrafast
infusion within 30 minutes in patients with non-Hodgkin's lymphoma.